Navigation Links
Microparts interest group workshop
Date:8/7/2009

Recent advances in modern manufacturing techniques has made it possible to manufacture small and complex components to extremely high accuracies. In direct response to the extreme demands of quality assurance for the measurement of size, form and position of microsystem parts, extensive research is being carried out in the area of geometrical measurement on the micro-scale.

'Microparts' is a joint EURAMET research project in the area of micro co-ordinate metrology for miniature components. VSL, NPL, PTB and METAS are collaborating on the project in all aspects of micro CMM technology including the development of novel contact, optical and XCT probing techniques, machine calibration, stability, traceability and calibration artefacts. The workshop aims to disseminate the work of the project to the wider audience and discuss related research and development topics.

Topics include:

  • Updates on the development of novel micro-CMM probes
  • Development of micro-CMM platforms
  • Calibration and traceability of micro-CMM platforms
  • Integrated micro metrology and micro manufacturing techniques

A workshop dinner will be held on the evening of the 28th October


'/>"/>

Contact: Joe Meaney
joe@proofcommunication.com
44-845-680-1864
National Physical Laboratory
Source:Eurekalert

Page: 1

Related biology technology :

1. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
2. Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again
3. Xspray Expands to Meet Pharmas Interest in its Ground-Breaking Particle Production Technology
4. Managing Conflict of Interest Disclosures Simplified for Healthcare Organizations
5. China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
6. deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
7. CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture
8. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
9. Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million
10. Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
11. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... Basel, Switzerland (PRWEB) , ... May 23, 2017 ... ... for R&D, celebrates this month its 20th anniversary, marking the occasion with a ... is sponsoring the meeting’s Welcome Reception and further extends an invitation to all ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... ... publication of “Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology ... the result of a collaboration with Dr. Dino Di Carlo and Dr. Matthew Rettig ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Bacterial biofilms, surface ... molecules, can cause diverse pathologies ranging from food poisoning and catheter infections to gum ... is in the tens of billions of dollars per year, there is currently a ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Stratevi, a ... expanded to the East Coast. It has opened an office in downtown Boston at ... are finding it increasingly more important to generate evidence on the value they provide, ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):